Report Detail
Global Influenza A Virus, H3N2 Subtype Infections Drug Market Insights, Forecast to 2025
- RnM3028341 |
- 26 February, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
The global Influenza A Virus, H3N2 Subtype Infections Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza A Virus, H3N2 Subtype Infections Drug market based on company, product type, end user and key regions.
This report studies the global market size of Influenza A Virus, H3N2 Subtype Infections Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza A Virus, H3N2 Subtype Infections Drug in these regions.
This research report categorizes the global Influenza A Virus, H3N2 Subtype Infections Drug market by top players/brands, region, type and end user. This report also studies the global Influenza A Virus, H3N2 Subtype Infections Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie Inc
AIMM Therapeutics B.V.
Aphios Corporation
Celltrion, Inc.
FluGen, Inc.
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
VBI Vaccines Inc.
Visterra, Inc.
Zydus Cadila Healthcare Limited
Market size by Product
NEO-8877
NP-025
NSC-61610
NVINF-1
Others
Market size by End User
Clinic
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Influenza A Virus, H3N2 Subtype Infections Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Influenza A Virus, H3N2 Subtype Infections Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Influenza A Virus, H3N2 Subtype Infections Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Influenza A Virus, H3N2 Subtype Infections Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Influenza A Virus, H3N2 Subtype Infections Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza A Virus, H3N2 Subtype Infections Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Influenza A Virus, H3N2 Subtype Infections Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Product
- 1.4.2 NEO-8877
- 1.4.3 NP-025
- 1.4.4 NSC-61610
- 1.4.5 NVINF-1
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size
- 2.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue 2014-2025
- 2.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales 2014-2025
- 2.2 Influenza A Virus, H3N2 Subtype Infections Drug Growth Rate by Regions
- 2.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Regions
- 2.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers
- 3.1.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers
- 3.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Manufacturers
- 3.1.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers
- 3.2.1 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Manufacturers
- 3.4 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Influenza A Virus, H3N2 Subtype Infections Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Product
- 4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Product
- 4.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Breakdown Data by End User
6 North America
- 6.1 North America Influenza A Virus, H3N2 Subtype Infections Drug by Countries
- 6.1.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Countries
- 6.1.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Influenza A Virus, H3N2 Subtype Infections Drug by Product
- 6.3 North America Influenza A Virus, H3N2 Subtype Infections Drug by End User
7 Europe
- 7.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug by Countries
- 7.1.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Countries
- 7.1.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug by Product
- 7.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug by Countries
- 8.1.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Countries
- 8.1.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug by Product
- 8.3 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug by End User
9 Central & South America
- 9.1 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug by Countries
- 9.1.1 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Countries
- 9.1.2 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug by Product
- 9.3 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug by Countries
- 10.1.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Countries
- 10.1.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug by Product
- 10.3 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug by End User
11 Company Profiles
- 11.1 AbbVie Inc
- 11.1.1 AbbVie Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.1.5 AbbVie Inc Recent Development
- 11.2 AIMM Therapeutics B.V.
- 11.2.1 AIMM Therapeutics B.V. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.2.5 AIMM Therapeutics B.V. Recent Development
- 11.3 Aphios Corporation
- 11.3.1 Aphios Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.3.5 Aphios Corporation Recent Development
- 11.4 Celltrion, Inc.
- 11.4.1 Celltrion, Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.4.5 Celltrion, Inc. Recent Development
- 11.5 FluGen, Inc.
- 11.5.1 FluGen, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.5.5 FluGen, Inc. Recent Development
- 11.6 Glide Pharmaceutical Technologies Limited
- 11.6.1 Glide Pharmaceutical Technologies Limited Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.6.5 Glide Pharmaceutical Technologies Limited Recent Development
- 11.7 ILiAD Biotechnologies, LLC
- 11.7.1 ILiAD Biotechnologies, LLC Company Details
- 11.7.2 Company Business Overview
- 11.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.7.5 ILiAD Biotechnologies, LLC Recent Development
- 11.8 Inovio Pharmaceuticals, Inc.
- 11.8.1 Inovio Pharmaceuticals, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.8.5 Inovio Pharmaceuticals, Inc. Recent Development
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.9.5 Johnson & Johnson Recent Development
- 11.10 Medicago Inc.
- 11.10.1 Medicago Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
- 11.10.5 Medicago Inc. Recent Development
- 11.11 MedImmune, LLC
- 11.12 Mucosis B.V.
- 11.13 NanoViricides, Inc.
- 11.14 OPKO Health, Inc.
- 11.15 Sarepta Therapeutics, Inc.
- 11.16 VBI Vaccines Inc.
- 11.17 Visterra, Inc.
- 11.18 Zydus Cadila Healthcare Limited
12 Future Forecast
- 12.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast by Regions
- 12.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Regions 2019-2025
- 12.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast by Product
- 12.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Product 2019-2025
- 12.3 Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast by End User
- 12.4 North America Influenza A Virus, H3N2 Subtype Infections Drug Forecast
- 12.5 Europe Influenza A Virus, H3N2 Subtype Infections Drug Forecast
- 12.6 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Forecast
- 12.7 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Forecast
- 12.8 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Influenza A Virus, H3N2 Subtype Infections Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Influenza A Virus, H3N2 Subtype Infections Drug . Industry analysis & Market Report on Influenza A Virus, H3N2 Subtype Infections Drug is a syndicated market report, published as Global Influenza A Virus, H3N2 Subtype Infections Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Influenza A Virus, H3N2 Subtype Infections Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
